Literature DB >> 18823778

Development of bestatin-based activity-based probes for metallo-aminopeptidases.

Michael B Harbut1, Geetha Velmourougane, Gilana Reiss, Rajesh Chandramohanadas, Doron C Greenbaum.   

Abstract

A novel set of activity-based probes (ABPs) for functionally profiling metallo-aminopeptidases was synthesized based on the bestatin inhibitor scaffold, the first synthesis of bestatin analogues using solid-phase techniques. These ABPs were shown to label metallo-aminopeptidases, using both a biotin and a fluorophore reporter, in an activity-dependent manner. This probe class was also shown to be amenable to 'click' chemistry labeling for possible use in live cells. Finally, we demonstrate that the ABPs are able to label an aminopeptidase in a complex proteome. Thus, these bestatin-based probes should have wide utility to functionally profile aminopeptidases in many biological systems.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18823778      PMCID: PMC2729790          DOI: 10.1016/j.bmcl.2008.09.021

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  25 in total

Review 1.  Aminopeptidases and angiogenesis.

Authors:  Yasufumi Sato
Journal:  Endothelium       Date:  2003

2.  Activity-based probes for protein tyrosine phosphatases.

Authors:  Sanjai Kumar; Bo Zhou; Fubo Liang; Wei-Qing Wang; Zhonghui Huang; Zhong-Yin Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2004-05-17       Impact factor: 11.205

3.  1,3-Dipolar Activity in Cycloadditions of an Aliphatic Sulfine(,)(1).

Authors:  Rolf Huisgen; Grzegorz Mloston; Kurt Polborn
Journal:  J Org Chem       Date:  1996-09-20       Impact factor: 4.354

4.  Leucine aminopeptidase: bestatin inhibition and a model for enzyme-catalyzed peptide hydrolysis.

Authors:  S K Burley; P R David; W N Lipscomb
Journal:  Proc Natl Acad Sci U S A       Date:  1991-08-15       Impact factor: 11.205

5.  Inhibition of aminopeptidase B and leucine aminopeptidase by bestatin and its stereoisomer.

Authors:  H Suda; T Aoyagi; T Takeuchi; H Umezawa
Journal:  Arch Biochem Biophys       Date:  1976-11       Impact factor: 4.013

6.  Profiling the specific reactivity of the proteome with non-directed activity-based probes.

Authors:  G C Adam; B F Cravatt; E J Sorensen
Journal:  Chem Biol       Date:  2001-01

7.  Polo-like kinases inhibited by wortmannin. Labeling site and downstream effects.

Authors:  Yongsheng Liu; Ning Jiang; Jiangyue Wu; Wei Dai; Jonathan S Rosenblum
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

8.  Induction of apoptosis by ubenimex (Bestatin) in human non-small-cell lung cancer cell lines.

Authors:  K Ezawa; K Minato; K Dobashi
Journal:  Biomed Pharmacother       Date:  1996       Impact factor: 6.529

Review 9.  Role of aminopeptidase in angiogenesis.

Authors:  Yasufumi Sato
Journal:  Biol Pharm Bull       Date:  2004-06       Impact factor: 2.233

Review 10.  Aminopeptidase N in arterial hypertension.

Authors:  Robert S Danziger
Journal:  Heart Fail Rev       Date:  2007-11-16       Impact factor: 4.214

View more
  5 in total

1.  Synthesis of new (-)-bestatin-based inhibitor libraries reveals a novel binding mode in the S1 pocket of the essential malaria M1 metalloaminopeptidase.

Authors:  Geetha Velmourougane; Michael B Harbut; Seema Dalal; Sheena McGowan; Christine A Oellig; Nataline Meinhardt; James C Whisstock; Michael Klemba; Doron C Greenbaum
Journal:  J Med Chem       Date:  2011-03-02       Impact factor: 7.446

2.  Bestatin-based chemical biology strategy reveals distinct roles for malaria M1- and M17-family aminopeptidases.

Authors:  Michael B Harbut; Geetha Velmourougane; Seema Dalal; Gilana Reiss; James C Whisstock; Ozlem Onder; Dustin Brisson; Sheena McGowan; Michael Klemba; Doron C Greenbaum
Journal:  Proc Natl Acad Sci U S A       Date:  2011-08-15       Impact factor: 11.205

Review 3.  Metallo-aminopeptidase inhibitors.

Authors:  Artur Mucha; Marcin Drag; John P Dalton; Paweł Kafarski
Journal:  Biochimie       Date:  2010-05-10       Impact factor: 4.079

Review 4.  The Impact of Activity-Based Protein Profiling in Malaria Drug Discovery.

Authors:  Luís A R Carvalho; Gonçalo J L Bernardes
Journal:  ChemMedChem       Date:  2022-05-19       Impact factor: 3.540

5.  Sitagliptin does not inhibit the M1 alanyl aminopeptidase from Plasmodium falciparum.

Authors:  Sheena McGowan
Journal:  Bioinformation       Date:  2013-07-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.